Page last updated: 2024-09-03

pramipexole and Allergic Encephalomyelitis

pramipexole has been researched along with Allergic Encephalomyelitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dutra, RC; Felipetti, FA; Gonçalves, ECD; Horewicz, VV; Lieberknecht, V; Martins, DF; Rabelo, BD; Rodrigues, ALS1
Barbosa, TA; Coelho, IS; Cunha, MP; Dafré, AL; de Souza, LF; Dutra, RC; Junqueira, SC; Lieberknecht, V; Rodrigues, AL; Santos, AR1

Other Studies

2 other study(ies) available for pramipexole and Allergic Encephalomyelitis

ArticleYear
Dopaminergic Receptors as Neuroimmune Mediators in Experimental Autoimmune Encephalomyelitis.
    Molecular neurobiology, 2021, Volume: 58, Issue:11

    Topics: Anhedonia; Animals; Axons; Brain-Derived Neurotrophic Factor; Corpus Striatum; Depression; Disease Progression; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Female; Interleukin-1beta; Lymph Nodes; Mice; Mice, Inbred C57BL; Neuroinflammatory Diseases; Oxidative Stress; Peptide Fragments; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Single-Blind Method; Spinal Cord

2021
Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice.
    Molecular neurobiology, 2017, Volume: 54, Issue:2

    Topics: Animals; Benzothiazoles; Dopamine Agonists; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3

2017